Ozan Pamir - Sep 4, 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
CFO
Signature
/s/ Ozan Pamir
Stock symbol
ATNF
Transactions as of
Sep 4, 2023
Transactions value $
$0
Form type
4
Date filed
9/6/2023, 06:30 PM
Previous filing
May 19, 2023
Next filing
Oct 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNF Common Stock 8.98K Sep 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Stock Option (Right to Buy) Award $0 +15K $0.00 15K Sep 4, 2023 Common Stock 15K $0.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
F2 The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.